1) Saprisartan
沙普立沙坦
2) eprosartan
依普罗沙坦
1.
Comparison of eprosartan and losartan in patients with mild to moderate essential hypertension;
依普罗沙坦与氯沙坦在轻中度原发性高血压病人中的降压疗效比较
2.
Metabolism of eprosartan does not require the cytochrome P450 enzyme system and has less drug-drug interactions.
依普罗沙坦是一个新型、高选择性血管紧张肽Ⅱ受体1拮抗药,尚具有改善血管内皮功能、延迟动脉粥样硬化、抗炎症等作用。
3) Eprosartan mesylate
甲磺酸依普罗沙坦
4) losartan potassium
氯沙坦钾
1.
Study on the formulation of losartan potassium tablets;
氯沙坦钾片剂的处方设计及其制备
2.
Assay and test for related substances of Losartan potassium by HPLC;
HPLC测定氯沙坦钾的含量及有关物质
3.
Determination of two components in compound losartan potassium tablets by capillary zone electrophoresis;
氯沙坦钾复方制剂毛细管区带电泳色谱分析
5) telmisartan
替米沙坦
1.
Study on the optimization synthesis of telmisartan;
替米沙坦合成工艺优化的研究
2.
An Improved Synthetic Method of Telmisartan;
替米沙坦的合成工艺改进
3.
Dissolution test for Telmisartan Dispersible Tablets;
替米沙坦分散片溶出度的测定方法
6) Olmesartan
奥美沙坦
1.
Determination of olmesartan concentration by LC-MS-MS assay in the human plasma;
LC-MS-MS方法检测人血浆中奥美沙坦的浓度
2.
Pharmacokinetics and bioequivalence of olmesartan medoxomil capsules;
奥美沙坦酯胶囊的人体药动学及生物等效性
3.
Efficacy and safety of olmesartan medoxomil tablet in patients with mild to moderate primary hypertension;
奥美沙坦治疗轻、中度原发性高血压的疗效和安全性
补充资料：依普罗沙坦
分子式：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条